Navigation Links
Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
Date:9/21/2010

an from its inception through its IPO on NASDAQ and as a public company until his retirement in 2009. Dr. Thompson is the former Vice President and General Manager of Chiron Informatics at Chiron Corporation and held various executive positions at Becton Dickinson, including Vice President Research and Technology Department of BD Bioscience. Dr. Thompson is a co-founder of iMetrikus, a clinical decision support company, where he served as CEO and Chairman. He is the founder and Managing Director of Strategicon Partners, an investment and management services company. He serves as a Director of Response Biomedical and CoDa Therapeutics. Dr. Thompson is an Ernst & Young Entrepreneur of the Year awardee, an inventor on numerous patents, a board-certified internist and oncologist, and was on staff at the National Cancer Institute following his internal medicine training at Yale University.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

The securities to be sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements.  Anthera has agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock, including the shares of common stock issuable upon exercise of the warrants, sold in the private placement. Anthera has agreed to file the registration statement within 30 days of the closing of the private placement. If any shares are unable to be included on the i
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
2. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
3. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
4. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
5. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
6. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
11. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... -- XRpro Sciences, Inc., a provider of a unique platform for ... and ion channel assays for the pharmaceutical industry, announced today ... MicroCap Conference on Thursday, May 28, 2015 in ... Hotel. The Company,s presentation by Richie Cunningham ... to begin at 1:30 p.m ET. Click here to view ...
(Date:5/26/2015)... England and PITTSBURGH , May 26, 2015 ... global pharmaceutical company, today announced that Mylan CEO ... Strategic Decisions Conference, Friday, May 29, 2015 at 9 ... a live webcast of the presentation via the investor ... An archived version will also be available following the ...
(Date:5/26/2015)... 26, 2015 Clinicient Inc , ... announced the results of an industry survey of ... 759 therapists, practice owners and administrative staff completed ... need for technology and services that improve therapist ... findings, Clinicient published a free 12-page guide to ...
Breaking Medicine Technology:XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2Survey: Half of Physical Therapists Underbill For Their Services 2
... JERUSALEM , June 2, ... oral drug delivery systems, announced,today that its subsidiary Oramed Ltd. ... ("Laser Detect"), an Israeli company listed on,the Tel Aviv Stock ... Entera Bio Ltd. ("Entera"). Under the terms of the agreement, ...
... Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) announced today that it ... June 10, 2010 at The Grand Hyatt Hotel in New York, ... will discuss the Company,s business strategy and historical financial performance at 11:30 ... , Attendance at ...
Cached Medicine Technology:Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 2Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 3Questcor to Present at the Jefferies 2010 Global Life Sciences Conference 2
(Date:5/26/2015)... Nurse Association of Northern NJ (VNA), is proud to serve ... for Life fundraiser. The event takes place Saturday, June 6th ... Hanover Ave, Morristown, NJ. At the event, teams will take ... to help the ACS support its vision of “a world ... estimated that more than 1.6 million new cases of cancer ...
(Date:5/26/2015)... This summer, ChopChop: The Fun Cooking Magazine for ... events in Greater Boston with a custom cargo bike. The ... Magazine, healthy snacks and other giveaways to encourage kids to ... to get our message of eating and cooking real food ... way,” explains Sally Sampson, Founder of ChopChop. “The ChopChop Try-cycle ...
(Date:5/26/2015)... May 26, 2015 Dermatologic surgeons performed ... 2014, according to survey results released today by the ... skin cancer treatments and several cosmetic categories, 2014 totals ... remained steady overall compared to 2013 figures. , ... treatments ranked as the most-performed procedure (3.08 million) by ...
(Date:5/26/2015)... May 26, 2015 Neeta Pai was ... nosebleeds and fainting spells, four of which landed her ... cardiac arrest. , Though she still struggles with ... to dedicate her time to increasing HHT awareness and ... there been awareness, we could have prevented all the ...
(Date:5/26/2015)... May 26, 2015 The American College of ... them for the Open House/Free Application Day on Wednesday, July ... until 4 p.m. and will be held at ACTCM Pioneer ... , After checking in, attendees will be greeted with an ... tour of the campus at 11:45 a.m. Lunch will be ...
Breaking Medicine News(10 mins):Health News:North Jersey Home Care Agency Supports Relay for Life Fundraiser 2Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:ACTCM to Host Summer Open House 2
... in all 604 districts of the country to provide essential ... has been set up to study the feasibility of ... Vilas Paswan Tuesday said that the committee has been formed ... fertilizer). ,"The committee will submit a report on ...
... day could help improve fitness and health of women who ... ,Conducting tests on overweight and obese women, many of whom ... Rouge found that even ten minutes of exercise a day ... their overall risk of early death. ,The study ...
... better be taken heed of, by bosses. The study shows ... to dire consequences, like a heart attack. ... College London and published in the Journal of Epidemiology and ... working in London for almost 11 years. ,The ...
... diet for any person depends on his physiology ... Optimal Weight for Life Program at Children's Hospital Boston, who ... fit all', also notes that heavy people with an apple ... lost a lot more pounds on a diet that excluded ...
... is more strongly linked to head and neck cancer than ... the Journal of the National Cancer Institute, showed that a ... to smoking. ,Led by Dr. Mia Hashibe ... researchers examined head and neck cancer risk among smokers who ...
... that women are significantly less likely than men to ... ,Elevated LDL cholesterol is an important modifiable ... of death for both women and men. ... Cardiovascular Disease: Using National Managed Care Performance Data to ...
Cached Medicine News:Health News:Feelings Of Injustice At Work Can Lead To A Heart Attack 2Health News:Check Your Physiology Before You Choose A Diet 2Health News:Women Less Likely to Control LDL Cholesterol Levels Than Men 2
... This comfortable pre-fabricated orthosis is designed ... distal third humeral diaphyseal fractures. The ... circumferential soft tissue compression for optimal ... full range-of-motion of both the shoulder ...
Provides secure fracture immobilization while allowing for full range of motion at shoulder and elbow...
... This night splint features a ... 10 degrees dorsiflexion, designed to provide ... symptoms of plantar fasciitis or Achilles ... the need to order left or ...
... This economically priced semi-rigid post op shoe ... soft cotton-poly blend breathable upper will keep ... hook and loop closure provides even tension ... additional comfort and support for your patient. ...
Medicine Products: